PETER SACCHETTI: Open Payments
NPI 1881799278 · KENNEBUNK, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$190 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $28 · 2025 $190
Food & beverage: $190
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| ABBVIE INC. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: TRINTELLIX, UBRELVY, AUSTEDO XR.
Industry payments across ME — which companies pay providers there.
